Summit Therapeutics Stock Options
| SMMT Stock | USD 19.75 0.31 1.59% |
Summit Therapeutics' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 1.01 with a put-to-call open interest ratio of 35.43 over 29 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on May 16th 2025. The total put volume is at 20.0, with calls trading at the volume of 12.0. This yields a 1.67 put-to-call volume ratio.
Open Interest Against May 16th 2025 Option Contracts
Summit Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Summit Therapeutics' lending market. For example, when Summit Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Summit Therapeutics, he or she must hedge the risk by shorting Summit Therapeutics stock over its option's life.
2025-05-16
The chart above shows Summit Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Summit Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Summit Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Summit Therapeutics
Analyzing Summit Therapeutics' in-the-money options over time can help investors to take a profitable long position in Summit Therapeutics regardless of its overall volatility. This is especially true when Summit Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Summit Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Summit Therapeutics' stock while costing only a fraction of its price.
Summit Current Options Market Mood
Summit Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Summit Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Summit Therapeutics' options investors are not very successful. Summit Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Summit contract
Base on the Rule 16, the options market is currently suggesting that Summit Therapeutics PLC will have an average daily up or down price movement of about 0.0631% per day over the life of the 2025-05-16 option contract. With Summit Therapeutics trading at USD 19.75, that is roughly USD 0.0125. If you think that the market is fully incorporating Summit Therapeutics' daily price movement you should consider buying Summit Therapeutics PLC options at the current volatility level of 1.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Summit |
Purchasing Summit Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Summit calls. Remember, the seller must deliver Summit Therapeutics PLC stock to the call owner when a call is exercised.
Summit Therapeutics Option Chain
When Summit Therapeutics' strike price is surpassing the current stock price, the option contract against Summit Therapeutics PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Summit Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Summit. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Summit. It also shows strike prices and maturity days for a Summit Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | SMMT250516C00040000 | 0 | 40.0 | 0.0 - 0.65 | 0.65 | |
Call | SMMT250516C00039000 | 0 | 39.0 | 0.0 - 0.65 | 0.65 | |
Call | SMMT250516C00038000 | 0 | 38.0 | 0.0 - 0.5 | 0.5 | |
Call | SMMT250516C00037000 | 0 | 37.0 | 0.0 - 0.5 | 0.5 | |
Call | SMMT250516C00036000 | 0 | 36.0 | 0.0 - 0.65 | 0.65 | |
Call | SMMT250516C00035000 | 0 | 35.0 | 0.0 - 0.65 | 0.65 | |
Call | SMMT250516C00034000 | 0 | 34.0 | 0.0 - 0.6 | 0.6 | |
Call | SMMT250516C00033000 | 0 | 33.0 | 0.0 - 0.55 | 0.55 | |
Call | SMMT250516C00032000 | 0 | 32.0 | 0.0 - 0.35 | 0.25 | |
Call | SMMT250516C00031000 | 0 | 31.0 | 0.0 - 0.45 | 0.45 | |
Call | SMMT250516C00029000 | 1 | 29.0 | 0.0 - 0.75 | 0.6 | Out |
Call | SMMT250516C00026000 | 5 | 26.0 | 0.65 - 1.05 | 1.2 | Out |
Call | SMMT250516C00025000 | 2 | 25.0 | 0.0 - 0.95 | 1.17 | Out |
Call | SMMT250516C00021000 | 21 | 21.0 | 1.75 - 1.95 | 2.42 | Out |
Call | SMMT250516C00020000 | 1 | 20.0 | 2.1 - 2.4 | 2.35 | Out |
Put | SMMT250516P00040000 | 0 | 40.0 | 18.9 - 21.8 | 18.9 | In |
Put | SMMT250516P00039000 | 0 | 39.0 | 18.0 - 20.8 | 18.0 | In |
Put | SMMT250516P00038000 | 0 | 38.0 | 17.8 - 19.3 | 17.8 | In |
Put | SMMT250516P00037000 | 0 | 37.0 | 16.5 - 18.7 | 16.5 | In |
Put | SMMT250516P00036000 | 0 | 36.0 | 16.2 - 17.2 | 16.2 | In |
Put | SMMT250516P00035000 | 0 | 35.0 | 14.1 - 16.8 | 14.1 | In |
Put | SMMT250516P00034000 | 0 | 34.0 | 13.7 - 15.7 | 13.7 | In |
Put | SMMT250516P00033000 | 0 | 33.0 | 12.2 - 14.7 | 12.2 | In |
Put | SMMT250516P00032000 | 0 | 32.0 | 11.8 - 13.8 | 11.8 | In |
Put | SMMT250516P00031000 | 0 | 31.0 | 10.7 - 12.5 | 10.7 | In |
Put | SMMT250516P00024000 | 48 | 24.0 | 5.3 - 5.8 | 5.1 | In |
Put | SMMT250516P00023000 | 1 | 23.0 | 4.3 - 4.8 | 4.8 | In |
Put | SMMT250516P00020000 | 10 | 20.0 | 2.6 - 2.95 | 2.6 | In |
Put | SMMT250516P00017000 | 1004 | 17.0 | 1.05 - 1.35 | 1.31 | Out |
Summit Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Summit Total Stockholder Equity
Total Stockholder Equity |
|
Summit Therapeutics Corporate Management
| Elaine JD | Head Counsel | Profile | |
| Fong Clow | Chief Officer | Profile | |
| Betty Chang | Oncology Research | Profile | |
| Bhaskar Anand | Chief Finance | Profile | |
| Will Black | Head Technology | Profile |
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.